Expert Perspectives in HF Lesson 4: Integrating Sacubitril/Valsartan

0 reviews

Haymarket Medical Education

30 minutes

PROGRAM DESCRIPTION In 2015, the US Food and Drug Administration (FDA) approved sacubitril/valsartan, making it one of the first pharmacologic therapies to emerge for chronic heart failure (HF) management in ...

Read more about this

I'm interested in this

Share with others

Write the first review

Join now
to leave a review or read peer reviews!

Resource tags
Show all tags


Sign Up

Share with others

I'm interested